Date published: 2026-5-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

Smad3 Inhibitors

Smad3 inhibitors constitute a distinct and intricate class of chemical compounds that exhibit a remarkable ability to modulate the intricate cellular signaling pathways closely associated with the Smad3 protein. Smad3, an essential intracellular mediator within the transforming growth factor-beta (TGF-β) signaling cascade, plays a pivotal role in orchestrating a wide array of fundamental cellular processes such as cell proliferation, differentiation, apoptosis, and immune regulation. Smad3 inhibitors have garnered significant attention due to their potential to exert regulatory control over the TGF-β pathway, thereby influencing a multitude of cellular responses without directly engaging in cellular therapy or intervention. These inhibitors are meticulously engineered to selectively target specific molecular elements within the intricate TGF-β signaling network. Their structural design often involves a meticulous approach, leveraging computational and structural biology insights to tailor the molecular architecture for optimal interaction with key components of the pathway. This strategic design ensures precise binding to the intended targets, such as the receptor-regulated Smad proteins and their associated kinases. By binding to these targets, Smad3 inhibitors disrupt crucial phosphorylation events that trigger downstream signaling cascades. The molecular interactions facilitated by Smad3 inhibitors can thwart the phosphorylation-driven activation of Smad3, hindering its subsequent translocation from the cytoplasm to the nucleus. This impediment disrupts the transcriptional activity of genes that are under Smad3's influence, consequently affecting cellular behaviors and functions. Some inhibitors may function by competitively occupying the active binding sites on the kinase enzymes that phosphorylate Smad3, whereas others may employ allosteric mechanisms to perturb the proper conformational changes required for effective signal transduction. The intricate interplay between the molecular structures of these inhibitors and the complex TGF-β pathway provides researchers with a valuable tool to delve deeper into the molecular mechanisms that underpin cellular responses to external cues.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Smad3 Inhibitor, SIS3

1009104-85-1sc-222318
1 mg
$257.00
36
(1)

Smad3 Inhibitor, SIS3 (CAS 1009104-85-1) is a compound that effectively targets and inhibits Smad3, a key protein involved in cellular signaling pathways. It modulates Smad3's activity, impacting cellular processes mediated by this protein.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

SB431542 is a small molecule inhibitor of TGF-β type I receptors, also known as ALK5 (Activin Receptor-Like Kinase 5). It prevents the activation of downstream SMAD proteins by blocking the phosphorylation of TGF-β receptor substrates.

LY2157299

700874-72-2sc-391123
sc-391123A
5 mg
10 mg
$213.00
$359.00
3
(1)

LY2157299 is a small molecule inhibitor of TGF-β type I receptor kinase. It has been investigated for its potential to inhibit fibrosis and tumor growth by interfering with TGF-β signaling.

TGF-β RI Kinase Inhibitor V

627536-09-8sc-203294
2 mg
$88.00
3
(1)

TGF-β RI Kinase Inhibitor V is another small molecule inhibitor of TGF-β type I receptor kinase. It has shown potential in research studies for fibrosis and certain cancers.

A 83-01

909910-43-6sc-203791
sc-203791A
10 mg
50 mg
$202.00
$811.00
16
(1)

A83-01 is a selective TGF-β type I receptor inhibitor that blocks the phosphorylation of SMAD2 and SMAD3, effectively attenuating downstream TGF-β signaling.

ALK5 Inhibitor II

446859-33-2sc-221234
sc-221234A
sc-221234B
sc-221234C
sc-221234D
sc-221234E
sc-221234F
1 mg
5 mg
10 mg
50 mg
100 mg
500 mg
1 g
$77.00
$153.00
$219.00
$663.00
$1248.00
$4382.00
$7850.00
8
(1)

ALK5 Inhibitor II is a small molecule inhibitor that targets both the TGF-β type I receptor and the ALK5 receptor. It is being investigated for its anti-fibrotic and anti-cancer properties.

EW-7197

1352608-82-2sc-507465
5 mg
$345.00
(0)

EW-7197 is an available small molecule inhibitor of TGF-β type I receptor kinase. It has demonstrated anti-fibrotic effects in research studies.